Minerva Neurosciences
NERV
33 hedge funds and large institutions have $108M invested in Minerva Neurosciences in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
2,459% more capital invested
Capital invested by funds: $4.21M → $108M (+$104M)
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
38% more funds holding
Funds holding: 24 → 33 (+9)
25.01% more ownership
Funds ownership: 28.31% → 53.32% (+25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$16.1M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$14.9M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$12.3M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.5M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$26.1K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$25.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$21.2K |
| 4 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
-$21.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LFG
26
Larson Financial Group
St Louis,
Missouri
| $1.61K | +$1.49K | +400 | New |
|
|
FFO
27
Fortitude Family Office
Scottsdale,
Arizona
| $1.22K | +$1.13K | +303 | New |
|
|
SS
28
SBI Securities
Tokyo,
Japan
| $1.01K | +$330 | +89 | +55% |
|
|
FFA
29
Farther Finance Advisors
San Francisco,
California
| $402 | – | – | – |
|
30
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $402 | – | – | – |
|
31
BNP Paribas Financial Markets
Paris,
France
| $249 | – | – | – |
|
32
Bank of America
Charlotte,
North Carolina
| $205 | +$4 | +1 | +2% |
|
|
AIM
33
Anchor Investment Management
Columbia,
South Carolina
| $48 | – | – | – |
|
|
ACM
34
ADAR1 Capital Management
Austin,
Texas
| – | -$26.1K | -12,406 | Closed |
|
|
RC
35
Rangeley Capital
New Canaan,
Connecticut
| – | -$21.1K | -10,000 | Closed |
|
|
GLF
36
Groupe la Francaise
Paris,
France
| – | -$603 | -337 | Closed |
|
37
Barclays
London,
United Kingdom
| – | -$2 | -1 | Closed |
|
38
Citigroup
New York
| – | -$2 | -1 | Closed |
|
NERV Hedge Fund Activity: Q4 2025 in Review
33 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2025, worth a combined $108M — up 2,459% from $4.21M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new NERV positions and 5 closed out — a net gain of 9 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Vivo Capital, opening a new position worth an estimated $16.1M. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $26.1K sold.
- 33 institutional investors held Minerva Neurosciences (NERV) as of Q4 2025, up from 24 in Q3 2025.
- Funds reported $108M of Minerva Neurosciences stock for Q4 2025, up 2,459% quarter-over-quarter.
- 14 funds opened new Minerva Neurosciences positions in Q4 2025 and 5 closed out, a net change of +9 holders.
- The largest Minerva Neurosciences buyer in Q4 2025 was Vivo Capital, an estimated $16.1M added.
- The largest Minerva Neurosciences seller in Q4 2025 was ADAR1 Capital Management, an estimated $26.1K sold.
Based on aggregated 13F filings for Q4 2025.